1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Cancer of Liver in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (11.11) | 18.7374 |
| 1990's | 3 (33.33) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, L; Fang, Z; Jia, D; Mi, J; Pan, Z; Peng, P; Shi, Z; Zhang, Y | 1 |
| He, XL; Qiu, H; Sun, XW; Wang, YH | 1 |
| Denizot, Y; Descottes, B; Labrousse, F; Mathonnet, M; Truffinet, V; Valleix, D | 2 |
| Thomson, DM | 1 |
| Biondo, S; Fabregat, J; Figueras, J; Fradera, R; Gijon, MA; Jaurrieta, E; Moreno, P; Rafecas, A; Sánchez-Crespo, M | 1 |
| Mochizuki, H; Ono, S; Tamakuma, S | 1 |
| Dong, X; Ekström, U; Nilsson-Ehle, P; Xu, N; Ye, Q; Zhang, XY | 1 |
| Hiramoto, M; Imaizumi, T; Kawamura, Y; Satoh, K; Takamatsu, M; Takamatsu, S; Yoshida, H | 1 |
1 trial(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Cancer of Liver
| Article | Year |
|---|---|
A clinical study on the significance of platelet-activating factor in the pathophysiology of septic disseminated intravascular coagulation in surgery.
Topics: Carcinoma, Hepatocellular; Data Interpretation, Statistical; Disseminated Intravascular Coagulation; Endotoxins; Gastrointestinal Neoplasms; Humans; Liver Neoplasms; Piperidines; Platelet Activating Factor; Pyridinium Compounds; Sepsis; Surgical Procedures, Operative | 1996 |
8 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Cancer of Liver
| Article | Year |
|---|---|
α-Hederin inhibits the platelet activating factor-induced metastasis of HCC cells through disruption of PAF/PTAFR axis cascaded STAT3/MMP-2 expression.
Topics: Carcinoma, Hepatocellular; Cell Line, Tumor; DNA-Binding Proteins; Humans; Liver Neoplasms; Matrix Metalloproteinase 2; Molecular Docking Simulation; Neoplasm Metastasis; Oleanolic Acid; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, G-Protein-Coupled; Saponins; Signal Transduction; STAT3 Transcription Factor | 2022 |
Prevention of venous thromboembolism after resection of primary liver cancer with low molecular weight heparin and its association with P-selectin, lysosomal granule glycoprotein, platelet activating factor and plasma D-dimer.
Topics: Adult; Aged; Female; Fibrin Fibrinogen Degradation Products; Heparin, Low-Molecular-Weight; Humans; Liver Neoplasms; Male; Middle Aged; P-Selectin; Platelet Activating Factor; Tetraspanin 30; Venous Thromboembolism | 2018 |
Platelet-activating factor and liver metastasis of colorectal cancer.
Topics: Antigens, Human Platelet; Colon; Colorectal Neoplasms; Epitopes; Female; Humans; Inflammation Mediators; Liver Neoplasms; Male; Middle Aged; Phospholipases A; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, G-Protein-Coupled; Rectum; RNA, Messenger | 2005 |
Platelet-activating factor in cirrhotic liver and hepatocellular carcinoma.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Adult; Aged; Carcinoma, Hepatocellular; Cell Communication; Female; Gene Expression Regulation; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Inflammation; Liver; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Neovascularization, Pathologic; Phospholipases A; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, G-Protein-Coupled; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transcription, Genetic | 2006 |
Various authentic chemoattractants mediating leukocyte adherence inhibition.
Topics: Carbonyl Cyanide m-Chlorophenyl Hydrazone; Cell Adhesion; Chemotactic Factors; Chemotaxis, Leukocyte; Complement C5; Complement C5a, des-Arginine; Humans; Leukocyte Adherence Inhibition Test; Leukocytes; Leukotriene B4; Liver Neoplasms; N-Formylmethionine Leucyl-Phenylalanine; Platelet Activating Factor; SRS-A; Structure-Activity Relationship; Tetradecanoylphorbol Acetate | 1984 |
Changes in peripheral blood levels of platelet-activating factor after orthotopic liver transplantation.
Topics: Adult; Biomarkers; Carcinoma, Hepatocellular; Female; Humans; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Platelet Activating Factor | 1993 |
Effects of platelet-activating factor, tumor necrosis factor, and interleukin-1alpha on the expression of apolipoprotein M in HepG2 cells.
Topics: Apolipoprotein A-I; Apolipoproteins; Apolipoproteins B; Apolipoproteins E; Apolipoproteins M; Dose-Response Relationship, Drug; Gene Expression; Hepatoblastoma; Humans; Imidazoles; Interleukin-1; Leucine; Lipocalins; Liver Neoplasms; Platelet Activating Factor; RNA, Messenger; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 2002 |
Platelet-activating factor (PAF) stimulates the production of PAF acetylhydrolase by the human hepatoma cell line, HepG2.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Acetophenones; Carcinoma, Hepatocellular; Cell Survival; Chromatography, Gel; Cycloheximide; Edetic Acid; Electrophoresis, Polyacrylamide Gel; Endopeptidases; Humans; Hydrolysis; Isoflurophate; L-Lactate Dehydrogenase; Liver Neoplasms; Methionine; Phospholipases A; Phospholipases A2; Phospholipids; Platelet Activating Factor; Precipitin Tests; Tumor Cells, Cultured | 1991 |